2013-04 |
Design and synthesis of Aurora kinase inhibitors as anticancer agents |
Abstracts of Papers - American Chemical Society. 2013 Apr;245:Article number 301-MEDI. |
|
2012-03-25 |
Design, synthesis, and SAR studies of duel FLT-3 and Aurora kinase inhibitors |
Abstracts of Papers - American Chemical Society. 2012 Mar 25;243:Article number 48-MEDI. |
|
2011-09-23 |
BPR1K653, a novel Aurora Kinase Inhibitor, exhibits potent anti-proliferative activity in P-gp170 (MDR1)-mediated VX680-resistant cancer cells in vitro and in vivo |
European Journal of Cancer. 2011 Sep 23;47:S127. |
|
2011-04 |
Antivascular activities of novel tubulin binding agent BPR0L075 |
Cancer Research. 2011 Apr;71:Abstract number 5309. |
|
2011-03-27 |
Design and synthesis of potent Aurora kinase inhibitors |
Abstracts of Papers - American Chemical Society. 2011 Mar 27;241:258-MEDI. |
|
2011-03 |
SAR studies of quinoline derivatives as novel anti-influenza agents |
Abstracts of Papers - American Chemical Society. 2011 Mar;241:81-MEDI. |
|
2011-03 |
Potent EGFR tyrosine kinase inhibitors as anticancer agents |
Abstracts of Papers - American Chemical Society. 2011 Mar;241:257-MEDI. |
|
2010-08 |
Lead optimization of furanopyrimidine Aurora kinase inhibitors: Development of in vivo active agents in tumor xenograft models |
Abstracts of Papers - American Chemical Society. 2010 Aug;240:MEDI 332. |
|
2009-09 |
Fast-forwarding kinase drug discovery: aurora and EGFR kinase inhibitor lead development |
EJC Supplements. 2009 Sep;7(2):96. |
|
2009-05 |
Down-regulation of survivin enhances sensitivity to BPROL075 in human cancer cells via caspase-independent mechanisms |
Cancer Research. 2009 May;69:Abstract number 5542. |
|
2009-03 |
Discovery and development of novel furano-pyrimidine analogs as Aurora kinase inhibitors |
Abstracts of Papers - American Chemical Society. 2009 Mar;237:MEDI 221. |
|
2007-07 |
Anti-influenza drug discovery |
Drugs of the Future. 2007 Jul;32(Suppl. A):97. |
|
2007-07 |
From bench to drug candidate: Design and synthesis of 5,6-fused heteroaromatics as anticancer agents |
Drugs of the Future. 2007 Jul;32(Suppl. A):34-35. |
|
2006-11 |
Combined modalities of resistance in an oxaliplaitin-resistant human gastric cancer cell line with enhanced sensitivity |
EJC Supplements. 2006 Nov;4(12):59. |
|
2006-09 |
MEDI 416-3- 2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino -3-methyl-butyr amide analogs as DPP-IV inhibitors for the treatment of type-II diabetes |
Abstracts of Papers - American Chemical Society. 2006 Sep;232:MEDI 416. |
|
2005-03 |
Promazine analogues as potential anti SARS-CoV drugs |
Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U168. |
|
2005-03 |
Design, synthesis and sar of indole-based PPAR agonists |
Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141. |
|
2005-03 |
Design and structure-activity relationships of novel indole-based PPAR agonists as antidiabetic agents |
Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141. |
|
2004-09 |
Drug design of BPR0L075 as an anticancer agent |
World Conference on Magic Bullets - Celebrating Paul Ehrlich's 150th Birthday. 2004 Sep 9-11:Abstract # 203. |
|
2004-08-22 |
Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents |
Abstracts of Papers - American Chemical Society. 2004 Aug 22;228:U924. |
|
2004-07 |
Drug design for BPR0L075 as an anticancer agent |
Medicine in the 21st Century Tri-Conference & Bio-Forum 2004 Shanghai International Convention Center. 2004 Jul. |
|
2003 |
The synthetic 1-aroylindoles and 3-aroylindoles derivatives, combretastatin A-4 analogues, as a novel class of potent anticancer agents |
2003 PSROC Annual Meeting. 2003. |
|
2002-08 |
Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents |
Abstracts of Papers of the American Chemical Society. 2002 Aug;224:076-MEDI. |
|